Online Amanita products show varied marketing and safety controls
Amanita Muscaria Mushrooms: An Online Retail Assessment of Branded Retailers, 2025.
AI Summary
This observational online retail assessment asked how Amanita muscaria products were marketed and sold in April 2025. Researchers reviewed the 13 most-trafficked websites they identified, rather than studying people or testing treatment effects. The products are relevant to public health because A. muscaria can cause serious poisoning, including delirium, coma, and death, and the FDA considers A. muscaria, its extracts, and certain constituents unapproved additives that do not meet the Generally Recognized as Safe standard for foods.
The assessment found that 8 of 13 websites (61.5%) used age questions and the same number had state-based shipping restrictions, while 9 (69.2%) offered discounts. Gummies were sold by 12 websites (92.3%), and chocolate bars by 5 (38.5%); some products also contained THCP and delta-9 THC. Marketing commonly included claimed effects, dosing instructions, and safety-related statements. Because this abstract reports a website snapshotβnot laboratory verification, consumer behavior, or clinical outcomesβit cannot establish the actual contents, safety, or health effects of products sold more broadly. This is an abstract-based summary and does not claim to have reviewed the full text.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Review finds mixed evidence on cannabis and tobacco co-use effects
Review finds promise in acidic cannabinoids, but human benefits remain unproven
A cancer-pain case report raises concern about THC/CBD with opioids
Explore More Research
Stay informed about the latest cannabis science.